OS | RFS | ||||||
---|---|---|---|---|---|---|---|
Characteristics | No. | Median survival (days) | Survival (%) | Log-rank | Median survival (days) | Survival (%) | Log-rank |
Age (y/o) | |||||||
<65 | 64 | 1026 | 70.3% | 0.330 | 999 | 67.2% | 0.851 |
≧65 | 55 | 952 | 63.6% | 952 | 63.6% | ||
Gender | |||||||
Female | 40 | 1007 | 70.0% | 0.761 | 1007 | 67.5% | 0.881 |
Male | 79 | 968 | 65.8% | 954 | 64.6% | ||
Differentiation | |||||||
Moderate, Well | 60 | 1047 | 70.0% | 0.354 | 1026 | 70.0% | 0.179 |
Poor, Undifferentiation | 57 | 937 | 64.9% | 1003 | 60.4% | ||
Stage | |||||||
I | 42 | 1035 | 85.7% | 0.003 | 1035 | 85.7% | 0.001 |
II, III | 75 | 934 | 57.3% | 921 | 54.7% | ||
Hepatitis B surface antigen | |||||||
Negative | 59 | 1003 | 69.5% | 0.552 | 982 | 66.1% | 0.861 |
Positive | 58 | 953 | 63.8% | 937 | 63.8% | ||
Hepatitis C virus | |||||||
Negative | 75 | 934 | 62.7% | 0.152 | 934 | 61.3% | 0.189 |
Positive | 37 | 994 | 75.7% | 955 | 73.0% | ||
CD133 (Cytoplasm) | |||||||
Low | 85 | 990 | 72.9% | 0.022 | 990 | 72.9% | 0.043 |
High | 34 | 943 | 52.9% | 944 | 52.9% | ||
CD133 (Nucleus) | |||||||
Low | 71 | 946 | 59.2% | 0.025 | 934 | 56.3% | 0.013 |
High | 48 | 1100 | 79.2% | 1076 | 79.2% |